Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-23

Clinical Trial Update: Normal Saline Infusion After Intravenous Thrombolysis in Stroke [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating normal saline infusion after intravenous thrombolysis in ischemic stroke is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Normal saline infusion (0.9% sodium chloride solution)

Snippet

Sponsor: Tianjin Medical University General Hospital | Conditions: Brain Infarction | Phase 3 | Status: NOT_YET_RECRUITING